2016
DOI: 10.3844/ajidsp.2016.1.10
|View full text |Cite
|
Sign up to set email alerts
|

Pterostilbene Enhanced Anti-Methicillin Resistant <i>Staphylococcus aureus</i> (MRSA) Activity of Oxacillin

Abstract: Methicillin-resistant Staphylococcus aureus (MRSA) is a deadly pathogen that initially was limited to hospital and healthcare facilities but has gradually became a growing problem in healthy children and adults. Pterostilbene belongs to the phenylpropanoid phytoalexin which is involved in plant response to various pathogen and herbivores attack. The aim of this study is to evaluate the anti-MRSA action of pterostilbene in combination with selected antibiotics; vancomycin, linezolid and oxacillin against ATCC 4… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
6
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 34 publications
2
6
0
Order By: Relevance
“…According to Sopirala et al [32] if the MIC of an antibiotic changed within a one-fold dilution, the result was considered as insignificant but because the decreased in the MIC of linezolid in this study was four-fold, the interaction could not possibly be indifference. However, the current FIC data was supported by our previous literature [23] that pterostilbene lacked interaction with linezolid despite the change in the MIC value of linezolid against both MRSA strains.…”
Section: Resultssupporting
confidence: 81%
See 2 more Smart Citations
“…According to Sopirala et al [32] if the MIC of an antibiotic changed within a one-fold dilution, the result was considered as insignificant but because the decreased in the MIC of linezolid in this study was four-fold, the interaction could not possibly be indifference. However, the current FIC data was supported by our previous literature [23] that pterostilbene lacked interaction with linezolid despite the change in the MIC value of linezolid against both MRSA strains.…”
Section: Resultssupporting
confidence: 81%
“…Pterostilbene was unique in that it showed lasting suppression of bacterial regrowth, but when employed with linezolid, the combination effect reduced its PAE. Based on the data in this study, we can postulate that pterostilbene could possibly have the same mechanism of action as that of linezolid as proposed in our previous finding [23] that pterostilbene could target the cell wall different from where oxacillin acts. Further studies to confirm that pterostilbene targets the bacterial protein different from the penicillin-binding protein where oxacillin acts are clearly needed to validate this hypothesis.…”
Section: Resultsmentioning
confidence: 80%
See 1 more Smart Citation
“…In comparison with gentamicin used as broad spectrum therapy against Gram-positive and Gram-negative infections, pterostilbene still showed 16 times lower antimicrobial activity against Staphylococcus aureus ATCC 25923 and Escherichia coli O157 and four times less inhibitory potency against Pseudomonas aeruginosa ATCC 15442. The same phenomenon was seen in the anti-MRSA effect of pterostilbene whereby both MRSA ATCC and clinical strains are less susceptible to pterostilbene compared to standard antibiotics [ 25 ]. On the other hand, the killing kinetics of Pseudomonas aeruginosa ATCC 15442 demonstrated bacteriostatic activity with less than 3 log 10 CFU/mL reductions in colony count at 24 h compared with the starting inoculum.…”
Section: Discussionmentioning
confidence: 79%
“…In previous studies, antimicrobial effect of model stilbene resveratrol and its related structures (e.g., piceatannol, pterostilbene, trans-piceid, and trans-ε-viniferin) has been reported against various food and human pathogenic microorganisms, such as Acetobacter aceti, Acetobacter oeni, Bacillus cereus, Bacillus subtilis, Dekkera bruxellensis, Escherichia coli, Listeria innocua, Listeria monocytogenes, Pseudomonas fluorescens, Pseudomonas aeruginosa, Streptococcus spp., Zygosaccharomyces bailii, and Zygosaccharomyces rouxii [11][12][13][14][15]. The in vitro growth-inhibitory effect of (E)-3-hydroxy-5-methoxystilbene, oxyresveratrol, pterostilbene, and resveratrol has also previously been described against S. aureus and Staphylococcus epidermidis [15][16][17][18].…”
Section: Introductionmentioning
confidence: 87%